tyloxapol has been researched along with gamma-tocopherol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, C; Ichikawa, T; Ikeda, S; Uchida, T; Yamashita, K | 1 |
| Brandys, J; Gawlik, M; Gawlik, MB | 1 |
2 other study(ies) available for tyloxapol and gamma-tocopherol
| Article | Year |
|---|---|
Triton WR1339, an inhibitor of lipoprotein lipase, decreases vitamin E concentration in some tissues of rats by inhibiting its transport to liver.
Topics: alpha-Tocopherol; Animals; Biological Transport; Chromans; gamma-Tocopherol; Lipoprotein Lipase; Liver; Male; Polyethylene Glycols; Rats; Rats, Wistar; Tocotrienols; Triglycerides; Vitamin E | 2007 |
The impact of Triton WR-1339 induced hyperlipidemia on the effects of benzo(a)pyrene or guaiacol on α- and γ-tocopherol pools and selected markers of pro-/antioxidative balance in rat plasma and erythrocytes.
Topics: alpha-Tocopherol; Animals; Benzo(a)pyrene; Carcinogens; Erythrocytes; gamma-Tocopherol; Guaiacol; Hyperlipidemias; Lipid Peroxidation; Lipids; Male; Malondialdehyde; Polyethylene Glycols; Rats; Rats, Wistar; Superoxide Dismutase; Surface-Active Agents | 2012 |